Chemours Co Stock Analysis
CC Stock | USD 21.82 0.10 0.46% |
Chemours Co is undervalued with Real Value of 25.51 and Target Price of 37.89. The main objective of Chemours stock analysis is to determine its intrinsic value, which is an estimate of what Chemours Co is worth, separate from its market price. There are two main types of Chemours' stock analysis: fundamental analysis and technical analysis.
The Chemours stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Chemours' ongoing operational relationships across important fundamental and technical indicators.
Chemours |
Chemours Stock Analysis Notes
About 83.0% of the company shares are held by institutions such as insurance companies. The book value of Chemours was currently reported as 4.4. The company has Price/Earnings To Growth (PEG) ratio of 1.67. Chemours last dividend was issued on the 15th of November 2024. The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. It employs 6400 people. For more info on Chemours Co please contact Mark Vergnano at 302 773 1000 or go to https://www.chemours.com.Chemours Quarterly Total Revenue |
|
Chemours Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Chemours' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Chemours Co or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Chemours had very high historical volatility over the last 90 days | |
The company generated the yearly revenue of 6.03 B. Annual Net Loss to common stockholders was (238 M) with gross profit of 1.62 B. | |
Chemours has a strong financial position based on the latest SEC filings | |
Over 83.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from gurufocus.com: The Chemours Co Stock Price Up 3.9 percent on Nov 21 |
Chemours Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Chemours previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
14th of February 2024 Upcoming Quarterly Report | View | |
25th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
14th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Chemours Largest EPS Surprises
Earnings surprises can significantly impact Chemours' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2016-05-02 | 2016-03-31 | 0.02 | 0.06 | 0.04 | 200 | ||
2024-03-27 | 2023-12-31 | 0.25 | 0.31 | 0.06 | 24 | ||
2017-02-15 | 2016-12-31 | 0.29 | 0.35 | 0.06 | 20 |
Chemours Environmental, Social, and Governance (ESG) Scores
Chemours' ESG score is a quantitative measure that evaluates Chemours' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Chemours' operations that may have significant financial implications and affect Chemours' stock price as well as guide investors towards more socially responsible investments.
Chemours Thematic Classifications
In addition to having Chemours stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
SyntheticsSynthetics production and silicon | ||
PlasticsRubber and plastics accessories | ||
Chemicals MakersChemicals for crops, soil, human, and animals | ||
ChemicalsUSA Equities from Chemicals industry as classified by Fama & French | ||
SRI Sustainable GrowthLarge and mid-sized companies that operate under the guidelines of socially responsible investing - SRI | ||
Trump EquitiesCompanies that have responded positively to Trump presidency |
Chemours Stock Institutional Investors
Shares | Lsv Asset Management | 2024-09-30 | 1.9 M | Norges Bank | 2024-06-30 | 1.7 M | Appian Way Asset Management | 2024-09-30 | 1.7 M | Luminus Management, Llc | 2024-09-30 | 1.6 M | Bank Of New York Mellon Corp | 2024-06-30 | 1.6 M | Massachusetts Financial Services Company | 2024-09-30 | 1.5 M | American Century Companies Inc | 2024-09-30 | 1.5 M | Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.5 M | Vision One Management Partners Lp | 2024-09-30 | 1.4 M | Fmr Inc | 2024-09-30 | 18.1 M | Blackrock Inc | 2024-06-30 | 16.3 M |
Chemours Market Capitalization
The company currently falls under 'Mid-Cap' category with a market capitalization of 3.28 B.Chemours Profitablity
The company has Net Profit Margin (PM) of 0.01 %, which suggests that even a small decline in it sales will erase profits and may result in a net loss, or a negative profit margin. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.1 %, which signifies that for every $100 of sales, it has a net operating income of $0.1.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.03) | (0.03) | |
Return On Capital Employed | (0.02) | (0.02) | |
Return On Assets | (0.03) | (0.03) | |
Return On Equity | (0.32) | (0.31) |
Management Efficiency
Chemours has Return on Asset (ROA) of 0.0397 % which means that for every $100 of assets, it generated a profit of $0.0397. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.1102 %, which means that it produced $0.1102 on every 100 dollars invested by current stockholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.03. The current year's Return On Capital Employed is expected to grow to -0.02. At present, Chemours' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 703.5 M, whereas Total Assets are forecasted to decline to about 7.5 B.Last Reported | Projected for Next Year | ||
Book Value Per Share | 4.96 | 8.77 | |
Tangible Book Value Per Share | 4.26 | 7.71 | |
Enterprise Value Over EBITDA | 39.56 | 41.53 | |
Price Book Value Ratio | 6.37 | 8.43 | |
Enterprise Value Multiple | 39.56 | 41.53 | |
Price Fair Value | 6.37 | 8.43 | |
Enterprise Value | 7.8 B | 5.3 B |
Chemours showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Dividend Yield 0.0456 | Operating Margin 0.0986 | Profit Margin 0.0132 | Forward Dividend Yield 0.0456 | Beta 1.745 |
Technical Drivers
As of the 28th of November, Chemours shows the risk adjusted performance of 0.0642, and Mean Deviation of 2.27. Chemours technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Chemours Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Chemours middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Chemours. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Chemours Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chemours insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chemours' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Chemours insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Picho Diane I. over two weeks ago Disposition of tradable shares by Picho Diane I. of Chemours at 19.04 subject to Rule 16b-3 | ||
Alvenia Scarborough over a month ago Acquisition by Alvenia Scarborough of 7903 shares of Chemours at 27.5 subject to Rule 16b-3 | ||
Shane Hostetter over three months ago Acquisition by Shane Hostetter of 26709 shares of Chemours subject to Rule 16b-3 | ||
Hostetter Shane over three months ago Insider Trading | ||
Camela Wisel over a year ago Acquisition by Camela Wisel of 5425 shares of Chemours subject to Rule 16b-3 |
Chemours Outstanding Bonds
Chemours issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Chemours uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Chemours bonds can be classified according to their maturity, which is the date when Chemours Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
US163851AH15 Corp BondUS163851AH15 | View | |
US163851AF58 Corp BondUS163851AF58 | View | |
Chemours 5375 percent Corp BondUS163851AE83 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View |
Chemours Predictive Daily Indicators
Chemours intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Chemours stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 51686.27 | |||
Daily Balance Of Power | (0.10) | |||
Rate Of Daily Change | 1.0 | |||
Day Median Price | 21.89 | |||
Day Typical Price | 21.86 | |||
Price Action Indicator | (0.12) | |||
Period Momentum Indicator | (0.10) | |||
Relative Strength Index | 48.56 |
Chemours Corporate Filings
F4 | 19th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 13th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 4th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 14th of August 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 13th of August 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
F4 | 8th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 7th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Chemours Forecast Models
Chemours' time-series forecasting models are one of many Chemours' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Chemours' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Chemours Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Chemours prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Chemours shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Chemours. By using and applying Chemours Stock analysis, traders can create a robust methodology for identifying Chemours entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.05) | (0.05) | |
Operating Profit Margin | (0.02) | (0.01) | |
Net Loss | (0.04) | (0.04) | |
Gross Profit Margin | 0.22 | 0.26 |
Current Chemours Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Chemours analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Chemours analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
37.89 | Buy | 10 | Odds |
Most Chemours analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Chemours stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Chemours, talking to its executives and customers, or listening to Chemours conference calls.
Chemours Stock Analysis Indicators
Chemours Co stock analysis indicators help investors evaluate how Chemours stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Chemours shares will generate the highest return on investment. By understating and applying Chemours stock analysis, traders can identify Chemours position entry and exit signals to maximize returns.
Begin Period Cash Flow | 1.3 B | |
Long Term Debt | 4 B | |
Common Stock Shares Outstanding | 148.9 M | |
Total Stockholder Equity | 737 M | |
Tax Provision | -81 M | |
Quarterly Earnings Growth Y O Y | -0.646 | |
Property Plant And Equipment Net | 3.5 B | |
Cash And Short Term Investments | 1.2 B | |
Cash | 1.2 B | |
Accounts Payable | 1.1 B | |
Net Debt | 3.1 B | |
50 Day M A | 19.4664 | |
Total Current Liabilities | 2.5 B | |
Other Operating Expenses | 6.1 B | |
Non Current Assets Total | 4.4 B | |
Forward Price Earnings | 8.5985 | |
Non Currrent Assets Other | 374 M | |
Stock Based Compensation | 18 M |
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |